Review On Prenatal And New-Born Genetic Testing Market (PCR, FISH, ACGH, NIPT And MSS): Global Industry Analysis, Size, Share, Growth, Trends And Forecast Opportunity 2013 - 2019

MarketReserchReports.biz  market Research study On “Prenatal And New-Born Genetic Testing Market”, is a comparative analysis of the global market.

Prenatal testing and diagnosis have enabled the detection of certain genetic abnormalities in as early as 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Prenatal and newborn genetic testing is referred to as the utilization of screening/diagnostic procedures for a fetus or a new born baby to detect chromosomal abnormalities such as Down syndrome, Patau syndrome and Edward syndrome. This report studies the global prenatal and newborn genetic testing market from two perspectives namely, types of technologies and the major geographic markets. The global prenatal and newborn genetic testing market by technology has been segmented as diagnostic technique and screening methods. Diagnostic technique is further classified as polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (aCGH). Similarly, screening methods are further categorized as non-invasive prenatal tests and maternal serum screening.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/181220

Geographically, the report segments the global prenatal and newborn genetic testing market into four main regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market sizes and forecasts for the period 2011 to 2019 in terms of revenue (USD million), considering 2012 as the base year, have been provided for each technology type and geographic region, along with their sub-segments (if any). The prenatal and newborn genetic testing market report also provides compounded annual growth rate (CAGR %) during the forecast period 2013 to 2019 for all the aforementioned segments.

The market overview section of the prenatal and newborn genetic testing market report discusses the market dynamics with respect to market drivers, restraints and opportunities. This section also covers market attractiveness analysis (by geography) and Porter’s five forces analysis for the global prenatal and newborn genetic testing market. Market share (%) for the major players operating in prenatal and newborn genetic testing market has also been provided for the year 2012, followed by a list of recommendations for the existing and new players to enter and enhance their market shares. The report concludes with the company profiles of key players operating in various segments of prenatal and newborn genetic testing market. Each company profile includes the business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the prenatal and newborn genetic testing market that have been profiled in this report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Natera, Inc. and Illumina, Inc.

Browse Our More Healthcare Market Related Reports @ http://www.marketresearchreports.biz/category/56

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

To View The Top Related News: http://www.marketresearchreports.biz/articles

Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Browse Blog At: http://chemicalmarketinginsights.blogspot.in

Thanks...........!!!!!!!!!!!

Pharmacovigilance Market (Phases Of Drug Development: Preclinical Studies, Clinical Trial Phase I, II, III & IV Or Post Marketing Surveillance; Type Of Methods: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, & EHR Mining; Type Of Service: In-House & Contract Outsourcing) - Global Industry Analysis And Forecast, 2014 - 2020

"Pharmacovigilance Market- Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020" studies the current scenario as well as future market potential of "Surgical Equipment" globally.

Intensifying regulatory expectations, tougher inspection system, and instant need for patient reporting boost the adoption rate of pharmacovigilance among pharmaceutical companies. Rise in the prevalence of acute and chronic diseases has consequently led to an increase in the incidences of drug consumption, thus leading to growth in the number of adverse drug events and drug toxicity cases. Furthermore, safety regulations, risk of high-profile safety issues, large volume of post-market events to be reviewed along with negative media coverage have bound the pharmaceutical players to take support of various outsourcing services for drug monitoring. Two major outsourcing providers preferred by pharmaceutical manufacturers for pharmacovigilance services are namely, traditional CROs (e.g. Covance, Inc., Quintiles Transnational, INC Research, etc.) and BPOs (e.g. Capgemini, Cognizant, Infosys Ltd., Tata Consultancy Services Limited, etc.). Outsourcing services do not only help in cost saving, but also support process efficiency. Pharmaceutical companies are now entering into long-term partnerships/service agreements with CROs and BPOs to reduce the pharmacovigilance process related expenditure, incurred right from drug discovery to post-marketing approvals. In addition, pharmacovigilance requires skilled resources with excellent language skills and strong knowledge pertaining to case reporting due to which pharmaceutical companies are opting for outsourced pharmacovigilance services in order to reduce the burden of clerical functions as well as capital expenditures.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/180425

This report provides a detailed analysis of the global pharmacovigilance market and assists in understanding various market regulating factors. The market overview section in this report provides analysis of the overall market trends and market dynamics such as market driving factors, restraining factors, and opportunities, which currently administrate the dynamics of the overall pharmacovigilance market. Additionally, the segment also provides and predicts the future circumstances of the market. Market monitoring tools such as Porter’s five forces analysis is also included in this study to provide analysis about the competition in the pharmacovigilance market and market attractiveness in various regions across the world. Competitive analysis tools such as market share analysis and market attractive analysis have also been included in the market overview section of the report to deliver a comprehensive status of the players in the global pharmacovigilance market. The executive summary provided in this report reflects the highlights of the study scope and the overall market in a summarized form. Furthermore, it includes a market snapshot, which provides a glance at the current scenario of the global pharmacovigilance market in terms of current and future market size and growth.

The global pharmacovigilance market is segmented on the basis of clinical trial phases, type of methods, service providers, and geography. Based on clinical trial phases, the pharmacovigilance market is segmented into preclinical studies, phase I trial, phase II trial, phase III trial, and phase IV trial (post marketing surveillance). Based on the methods, this study segments the market into spontaneous reporting, targeted reporting, cohort event monitoring, Intensified ADR, and Reporting EHR mining. Based on service providers, the global pharmacovigilance market is categorized into in-house and contract outsourcing. The market size estimations for the period from 2012 to 2020 have been provided for each segment in terms of USD million. Compounded annual growth rates (CAGR %) for each segment has been provided for the period between 2014 and 2020, considering 2013 as the base year.

Browse More Reports Of This Publisher: http://www.marketresearchreports.biz/publisher/14

In terms of regional analysis, the global pharmacovigilance market has been segmented into four key geographies: North America, Europe, Asia Pacific, and Rest of World (RoW). Market revenue estimations for each of these geographies have been provided in the report for the period from 2012 to 2020 in terms of USD million, considering 2013 as the base year for calculations and 2012 as the historical year. The CAGR (%) of each market segment for the forecast period from 2014 to 2020 has also been provided along with market size estimations. This study also provides recommendations for players of the global pharmacovigilance market, which include aspects that may play a decisive role in improving the market share.

The report concludes with in-depth profiles of leading players, which include key information about the major organizations dynamically involved in the global pharmacovigilance market. The report profiles the key market players in terms of company overview, financial overview, product portfolio, business strategies, and recent developments. The key companies profiled in this study are Accenture, Plc, Clinquest Group B.V., Cognizant Technology Solutions, Covance, Inc. ICON, Plc, iMED Global Corporation, inVentiv Health, Inc., Parexel International Corporation, Pharmaceutical Product Development LLC, PRA Health Sciences, Inc., Quintiles Transnational Holdings Inc, F. Hoffmann-La Roche Ltd., Sanofi , Synowledge LLC, Wipro Limited. Market share analysis of the organizations operating in the pharmacovigilance market would help new entrants to understand key business policies and identify product portfolio of established companies.
 
The global pharmacovigilance market is segmented as follows:

Pharmacovigilance Market, by Phases of Drug Development
Preclinical Studies
Phase I
Phase II
Phase III
Phase IV or Post Marketing Surveillance
Pharmacovigilance Market, by Type of Methods
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
Pharmacovigilance Market, by Type of Service
In-House
Contract Outsourcing
Pharmacovigilance Market, by Geography
North America
Europe
Asia Pacific
Rest of the World (RoW)

Browse Our Surgical Equipment Related More Reports: http://www.marketresearchreports.biz/category/53

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

To View The Top Related News: http://www.marketresearchreports.biz/articles

Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Browse Blog At: https://geekmarketbuzz.wordpress.com/

Safety Syringes Market (Retractable Safety Syringes: Automatic Retractable Safety Syringes And Manual Retractable Safety Syringes, And Non-Retractable Safety Syringes) - Global Industry Analysis, Volume, Share, Growth, Trends And Forecast Opportunity 2013-2019

Marketresearchreports.biz has added a new research report on "Safety Syringes Market- Global Industry Analysis, Size, Volume, Share, Growth, Trends And Forecast, 2013 - 2019" to its collection. Explore All Pharmaceutical Market Research Reports at http://www.marketresearchreports.biz/category/38

The report on safety syringes market provides comprehensive information about the various facets of the market from detailed product analysis, market trends and future opportunities to the competitive landscape. The two major segments described in the study are retractable safety syringes and non-retractable safety syringes. Retractable safety syringes have been further categorized as the automatic retractable safety syringes and manual retractable safety syringes. Non-retractable safety syringes account for all those syringes without retractable mechanism such as sheathing tube syringes, syringes with sliding needle covers and hinged needle covers. Each of these product types and sub-types has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2011 and 2012 as the base years.

In terms of geography, the market for safety syringes has been segmented into four major regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The current and future market size in terms of USD million and market volume in terms of million units for each of these regions along with CAGR have also been provided in the report. The study also provides a detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter’s five forces analysis and market attractiveness analysis pertaining to the safety syringes market in the market overview section of the report. The market overview section of the report also includes the qualitative and quantitative analysis of the competitive landscape. The study also suggests a list of recommendations that is likely to help manufacturers of this market in decision making process.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/196244

The report concludes with the company profiles of the key players operating in this market. Becton, Dickinson & Company, Covidien plc, Retractable Technologies, Inc., Revolutions Medical Corporation, Smiths Medical, Terumo Corporation and Unilife Corporation are the major players profiled in this report.

The global safety syringes market is segmented as follows:

Safety Syringes Market, by Product Type
Retractable Safety Syringes
Automatic Retractable Safety Syringes
By Revenue (USD Million)
By Volume (Million Units)
Manual Retractable Safety Syringes
By Revenue (USD Million)
By Volume (Million Units)
Non Retractable Safety Syringes
By Revenue (USD Million)
By Volume (Million Units)
Safety Syringes Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Browse Our Press Releases by Prnewswire: http://www.prnewswire.com/news/marketresearchreports.biz

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

To View The Top Related News: http://www.marketresearchreports.biz/articles

Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Browse Blog At: https://geekmarketbuzz.wordpress.com/

Thanks...........!!!!!!!!!!

Smoking Cessation And Nicotine De-Addiction Products Market Research Strategy- Global Industry Analysis, Share, Growth, Trends And Forecast Opportunity 2013 - 2019

“Smoking Cessation And Nicotine De-Addiction Products Market”, is a comparative analysis of the global market for Healthcare is The has recently announced the additional market study By MarketReserchReports.biz

Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), and Chantix/Champix (varenicline). Smoking de-addiction is also possible with or without assistance of healthcare professionals. The smoking cessation products market has been extensively analyzed on the basis of factors such as the products popularly used, success rate, and geographical reach.

This report studies the global smoking cessation and nicotine de-addiction products market from the perspective of various product types available in the market. These include nicotine replacement therapy (NRT) products, drug therapy and e-cigarettes. The NRT products market is broadly segmented into nicotine containing gums, transdermal patches, lozenges, sublingual tablets, sprays and nasal inhalers. The prominently used brands for smoking cessation are Zyban and Chantix/Champix which comprise the drug therapy segment of the market. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia Pacific and Rest of the World (RoW).

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/192907

Each of the segments have been analyzed on the basis of their current and future market size for the period 2011 to 2019, in terms of revenue (USD million), considering 2011 and 2012 as the base years. The compounded annual growth rate (% CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size.

A competitive landscape, mapping all the market players and their respective shares in the smoking cessation and nicotine de-addiction products market for 2012 are provided in this report. Some of the major players profiled for NRT products include Johnson & Johnson, GSK, Pfizer, Takeda Pharmaceuticals Co. Ltd., Cipla, and Revolymer PLC. GSK and Pfizer lead the market for drug therapy while the key players profiled for e-cigarettes market include VMR products, and NJOY. Each of these smoking cessation and nicotine de-addiction products market players are profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.

Browse Our More Healthcare Related Reports: http://www.marketresearchreports.biz/category/56

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

To View The Top Related News: http://www.marketresearchreports.biz/articles

Contact 
Mr. Nachiket 
90 Sate Street, Suite 700 
Albany, NY 12207 
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Browse Blog At: https://geekmarketbuzz.wordpress.com/

Push Telecommunications For Tele-Medicine (PTT) And M-Health Market Segments: Market Shares, Strategy, And Forecasts, Worldwide, 2015 To 2021

New Report analyzes and presents an overview of "Push Telecommunications For Tele-Medicine (PTT) And M-Health: Market Shares, Strategy, And Forecasts, Worldwide, 2015 To 2021" worldwide.

The 2015 study has 815 pages, 259 tables and figures. Worldwide markets are poised to achieve significant growth as the push systems are used inside telemedicine systems and m-health apps to move patient and clinician communication in a secure manner to and from the person or clinician that needs the healthcare information. Telecommunications initiatives are being implemented with handset and tablet communications for all patients and clinicians.

Tele-medicine and M-health market driving forces relate to people taking more responsibility for their own health. Tele-medicine and m-health contribute to healthcare delivery in the home and office. M-health, delivered over the smart phone and tablet, comes in the form of apps. Tele-medicine is evolving toward smart phone device delivery as well.

The cost of tele-medicine for the US veterans administration is $1,630 per patient per annum. This is substantially less than skilled nursing facility programs and nursing home care which cots $100,000 per annum. VHA's positive experience with enterprise-wide home tele-medicine implementation is driving adoption by hospitals everywhere. Telemedicine is an appropriate and cost-effective way of managing chronic care patients in both urban and rural settings.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/270539

The tele-medicine adoption rate is growing. Cost of care delivery has become a major concern worldwide as the population ages. Mobile phone apps and remote telemedicine equipment are driving increased adoption, growing adoption rates. Concerns regarding the efficacy of care through use of tele-medicine in healthcare industry have alleviated. Reimbursement is being made available for clinicians for the use of tele-medicine.

Patients are being encouraged to take more responsibility for their own care. Technology is bringing change. People have more accurate information available to themselves. The current situation is impacted by the very high proportion medical spending that is directed to treatment of chronic disease. A second aspect is that chronic conditions are best controlled by interventions on a daily basis with a trusted nurse monitoring and measuring outcomes of various situations.

The tele-monitors integrates with the management suites to empower care providers within healthcare systems, physician offices, or home health agencies with web-enabled, on-demand access to this configurable device. Wireless connectivity with a broad range of peripheral devices supports patients with a variety of the needs and risk factors.

Medical consultation systems to allow healthcare providers to remotely monitor patients around-the-clock. Voice-enabled, disease-specific symptom management (DSSM) questions are part of the system. Protocols (include multi-level questions. Multilevel questions sets can be triggered by yes or no answers.

This level of granularity enables care providers to telemonitor patients with chronic diseases. Disease conditions monitored include hypertension, COPD, CHF, and diabetes. Honeywell network of remote patient monitors consists of 70,000 installed units. This is a significant installed base. Honeywell offers a complete and flexible telemonitoring system. Accurate vital signs collection is improved with clear auditory and visual cues to the patient.

This study deals with three separate related markets. Telemedicine is the tracking and monitoring of chronic disease. Vital signs and advice are core parts of the business. M-health is a separate business related to the development of apps that are providing monitoring through smart phones and tables, and are providing wellness applications. Tele-health is a related market. In tele-health, companies, enterprises, and insurers contract with a services provider to be available on the telephone to help people deal with a virus, an infection, poison ivy, pink eye, and common disease conditions that can be managed with telephone or video communications..

M-Health relates to apps. The app helps healthcare providers meet patients where they are, enabling just-in-time patient education and care coaching through the power of the mHealth. Health Groups are evolving worldwide leadership positions in mobile health systems with millions using its mobile health applications on iOS and Android, enjoying the personal and family benefits of being led to live a more active, healthier lifestyle.

Push telecommunications for tele-medicine (PTT) and M-health supports custom messaging from patients on a daily basis. Messaging is a feature of the Bosch Health Buddy System and other leading telemedicine systems. The systems rely on content programs that are tailored to patient conditions and involve questionnaires tailored to the chronic condition in the case of patients with those types of disease conditions.

With chronic disease telemedicine systems, content is pushed out to the patient on a custom basis, addressing changes in patient condition. Content varying is implemented each day to assess different key aspects of care and to keep the experience fresh for patients. The custom messaging feature enables care providers to send customized notifications to specific patients or their entire population with the click of one button. Messages appear on the patient’s device display on their next session, and are archived and audited by the system, allowing the care provider to track when patients receive and view their messages.

In the case of remote presence telemedicine systems and video conferencing systems, the care giver needs to have access to the patient record. In the long term, this will be how the systems all work, that the physician talking to the patient has the ability to see the test results and the patient history.

There is strong market growth in all segments, but the most dramatic is in the smart phone apps segment. Electronic personal monitoring and profiling of healthy behaviors will grow dramatically. The unprecedented availability of sensors that detect sleep patterns, exercise patterns, and correlate these with vital signs monitoring is bringing a huge change to living.

Just as sports clubs have created a way for people to exercise instead of going to the bar, so also smart phones will encourage healthy behaviors. The information gathered will make its way into the electronic patient record, feeding ways for physicians to encourage compliance. Apps at $.99 each will predominate, linking to cognitive computing systems in the cloud.

The analytical capabilities of cognitive computers help people make sense of the accumulated information about lifestyle and will help people make more intelligent choices about lifestyle. Tele-medicine device and software companies recognize that their revenue stream will come from services delivery. Just as smart phones are paid for in conjunction with the services contracts, so also the tele-medicine applications are paid by insurance.

In some cases the insurance companies recognize that their long term costs are lower by delivering clinical intervention to try to impact lifestyle for patients with chronic disease conditions. Early intervention is dramatically less expensive than a trip to the emergency ward. (ER)

IBM Watson cognitive computing drives the M-health market with its cloud computing analytics available to a number of market participants. Healthcare patient, physician, and facility decision support markets are forecast based on the broad availability of smartphones combined with the IBM Watson technology that promises to revolutionize care delivery for every healthcare venue.

Watson offers Interactive Care Insights for Oncology. The cognitive systems use insights gleaned from the deep experience of Memorial Sloan-Kettering and Massachusetts General Hospital clinicians. Watson is positioned to permit clinicians to provide individualized treatment. More options are based on patient medical information. IBM Watson in combination with Memorial Sloan-Kettering Cancer Center has information that represents the synthesis of a vast array of updated and vetted treatment. It is able to compute individual treatment guidelines. This represents a revolution in cancer treatment care and presages a major revolution in all healthcare treatment and diagnosis.

Teladoc, Inc. provides telehealth services in the United States. It has a stable of doctors that perform diagnoses, recommend treatment, and prescribe medication for various medical issues, including cold and flu symptoms, bronchitis, allergies, poison ivy, pink eye, urinary tract infection, respiratory infection, sinus problems, ear infection, and more.

Teladoc is the largest telehealth provider in the nation, founded in 2002. Teladoc provides 24/7/365 access to U.S board-certified doctors. Telehealth services are available when needed. Teladoc is the nation’s leading telehealth provider with 10 million members and 300,000-plus consults annually. Teladoc provides 24/7 access to affordable, high-quality medical care for adults and children experiencing non-emergency medical issues via phone, secure online video, mobile app or HealthSpot™ Station – a private, walk-in kiosk. Through a directly-managed network of U.S.-based, board-certified physicians, Teladoc delivers a 95 percent patient satisfaction rate with an average response time of eight minutes.

Teladoc client EMC Corporation Teledoc works closely with the Director of Benefits to leverage telemedicine services for employees. Telemedicine is offered as part of benefits packages. Teledoc provides employees with greater access to convenient, high quality medical care.

Worldwide Tele-medicine and M-health PTT push market driving forces relate to the improved effectiveness of remote communications in all industries. An clinical reimbursement addressing mobile health initiative for chronic conditions. This trend promises to become prevalent as people learn how to keep themselves healthier. Healthy behaviors such as exercise, good diet and stress management have the potential to reverse aging on a molecular level and partly restore the vitality of a person's cells.

Healthy lifestyle choices can increase the length of DNA sequences found at the end of a person's chromosomes. This shift toward wellness has stimulated the need for better communication between clinicians and patients. New sensor technology creates the opportunity for monitoring and for alerts to be send to and from at risk people who are exercising.

PTT telemedicine markets are poised to achieve significant growth as the existing telemedicine systems merge with the smart phone systems of engagement to provide a way to improve clinical care delivery to patients with chronic disease, decreasing hospitalizations and visits to the emergency room. There is a convergence of telemedicine and m-health as the patients become more responsible for their own care delivery and their own health.

According to Susan Eustis, lead author of the WinterGreen Research team that prepared the telemedicine market research study, “Push technology for telemedicine (PTT) is evolving large new markets. Markets are evolving as smart phone devices find more uses. Differential diagnostic tools and significant improvements in monitoring support differential tele-medical treatment. The decision process takes into account clinical findings from home monitoring devices and from symptoms verbally communicated in a clinical services implementation.”

Tele-medicine, telehealth, and m-health contribute to healthcare delivery. M-health will surely be delivered over the smart phone and tablets. Tele-medicine is evolving toward smart phone device delivery as well. The cost of tele-medicine is substantially less than other NIC programs and nursing home care. VHA's experience is that an enterprise-wide home tele-medicine implementation is an appropriate and cost-effective way of managing chronic care patients in both urban and rural settings.

Chronic disease conditions are best treated early on when there is a change in patient condition and an early intervention can make a difference. It is even better to treat them in a wellness treatment environment before there are indications of chronic disease, before symptoms develop, by addressing lifestyle issues early on.

Telemedicine, telehealth, and M-health markets at $1.5 billion in 2014 are anticipated to reach $45.4 billion by 2021. M-Health markets related to telemedicine will grow the fastest, leveraging 9.5 billion smart phones and 5 billion connected tablet devices installed all over the world by 2021.

WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, Electronics.CA, Bloomberg, and Thompson Financial.

WinterGreen Research is positioned to help customers face challenges that define the modern enterprises. The increasingly global nature of science, technology and engineering is a reflection of the implementation of the globally integrated enterprise. Customers trust WinterGreen Research to work alongside them to ensure the success of the participation in a particular market segment.

WinterGreen Research supports various market segment programs; provides trusted technical services to the marketing departments. It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally. These are all vital market research support solutions requiring trust and integrity.

Browse Our More Healthcare Related Reports: http://www.marketresearchreports.biz/category/56

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

To View The Top Related News: http://www.marketresearchreports.biz/articles

Contact 
Mr. Nachiket 
90 Sate Street, Suite 700 
Albany, NY 12207 
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/

Trends On The MHealth (Mobile Healthcare) Ecosystem: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts

MarketResearchReport.Biz analyzes and presents an overview of "The MHealth (Mobile Healthcare) Ecosystem: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts" worldwide.

With more than 7 Billion mobile network subscriptions worldwide, the mobile communications sector is rapidly gaining traction from a diverse range of vertical sectors. Healthcare is no exception to this trend.

As healthcare providers seek to maximize their patient outreach while minimizing costs, many view mobile healthcare (or mHealth) as the solution to improve healthcare cost–efficiency. mHealth refers to the usage of mobile communications technology & devices to enhance access to healthcare information, improve distribution of routine and emergency health services and provide diagnostic services.

Mobile network operators also view mHealth as a lucrative opportunity for the monetization of their mobile connectivity services as a growing proportion of their subscribers adopt healthcare centric wearables. Given that most operators have established themselves as reputable consumer brands, they are also eyeing on opportunities to offer services beyond simple connectivity. Many operators already offer branded or co-branded end-to-end mHealth solutions to their customer bases.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/353967

In addition, mHealth offers a multitude to opportunities to the pharmaceutical industry ranging from R&D activities to securing the supply chain and, in the battle against counterfeit drugs.

Driven by the thriving ecosystem, SNS Research estimates that the mHealth market will account for nearly $18 Billion in 2016 alone. Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Research estimates further growth at a CAGR of 40% over the next 5 years.

The “mHealth (Mobile Healthcare) Ecosystem: 2015 – 2030 – Opportunities, Challenges, Strategies & Forecasts“ report presents an in–depth assessment of the global mHealth market. In addition to covering key market drivers, challenges, future roadmap, value chain analysis, deployment case studies, service/product strategies and strategic recommendations, the report also presents comprehensive forecasts for the mHealth market from 2015 till 2030. The forecasts and historical revenue figures are individually segmented for 5 individual submarkets, 29 use case categories, 5 ecosystem player categories, 6 geographical regions and 34 countries.

The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.

Related Reports

1. Impact Of US Healthcare Reforms - The Extension Of Care To 32 Million Uninsured Citizens From 2014 And Implications For The Pharmaceutical Industry

2. Critical Healthcare Market To 2017 - Shift Of Focus Towards PCC, Factor Concentrates And Antithrombins Due To Better Safety And Efficacy Profiles

3. Long Term Care And Nursing Home Information Systems Market Shares, Strategies, And Forecasts, Worldwide, 2010 To 2016

Topics Covered

The report covers the following topics:

The scope and implementation of mHealth across the globe
mHealth technology
Market drivers and key benefits of mHealth
Challenges and inhibitors to the mHealth ecosystem
mHealth standardization and regulatory initiatives
mHealth opportunities, use cases and applications
mHealth deployment case studies
Value chain analysis of the mHealth ecosystem and the recognition of key players in each segment of the value chain
mHealth industry roadmap: 2015 – 2030
Key trends in the mHealth ecosystem; mHealth regulation & security, adoption of cloud based mHealth services, alliances for ecosystem fortification, and the impact of LTE deployments
The role of M2M and wearable technology in the mHealth ecosystem 
Profiles and strategies of over 200 ecosystem players
Strategic recommendations for mobile network operators, wireless infrastructure/device OEMs, application developers, healthcare service providers & pharmaceutical companies to capitalize on the mHealth opportunity
In-depth analysis for

5 individual submarkets and their associated mHealth application use cases:

Pharmaceutical Applications
Medical Information & Healthcare Management
Healthcare & Fitness
Remote Consultation/Diagnostic Services
M2M, Wearable Technology, Sensor & Monitoring Applications 
Historical revenue figures and forecasts till 2030
Forecast Segmentation

Market forecasts and historical revenue figures are provided for each of the following 5 submarkets and their 23 use case categories:

Pharmaceutical Applications
Safety Data Collection
Consumer Education
Medical Education
Post–Market Monitoring
Drug Authentication
Social Media
Patient Compliance & Retention: Clinical Trials
Information & Healthcare Management

Electronic Health/Medical Records & Tracking Tools
Diagnostic Tools & Medical Reference
Continuing Medical Education
Awareness Through Alerts
Logistical & Payment Support
Healthcare & Fitness

Medical Compliance
Fitness & Nutrition Apps
Clinical Decision Support Systems
Prescribable Mobile Apps
Remote Consultation/Diagnostic Services

Mobile Video Consultations, Collaboration & Surgery
Non-Video Consultations & Collaboration
Remote Collaboration in Emergency Situations
M2M, Wearable Technology, Sensor & Monitoring Applications

Health and Wellness Monitoring
Disease Surveillance/Remote Monitoring
Diagnostic Tools
Technical Logistics
Revenue is also split by ecosystem player:

Ecosystem Player
Mobile Network Operators/Connectivity Providers
Mobile & mHealth Device OEMs
Content & Application Providers
Healthcare Service Providers
Pharmaceutical Industry
The following regional and country markets are also covered:

Regional Markets
Asia Pacific
Eastern Europe
Latin & Central America
Middle East & Africa
North America
Western Europe
Country Markets

Argentina, Australia, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, India, Indonesia, Israel, Italy, Japan, Malaysia, Mexico, Norway, Pakistan, Philippines, Poland, Qatar, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, UAE, UK, USA

Additional forecasts are provided for the following:

Wireless M2M connections for the mHealth vertical
mHealth centric wearable device shipments
Mobile video calling users
Annual throughput of mobile network data traffic
Smartphone, feature phone, tablet, desktop PC and notebook shipments
Mobile network subscriptions by region
Cost saving potential of mHealth by region
Big Data & analytics technology investments in the healthcare sector

Key Questions Answered

The report provides answers to the following key questions:

What are the key market drivers and challenges for the mHealth ecosystem?
What are the key applications of mHealth?
How is the mHealth value chain structured and how will it evolve overtime?
What opportunities does mHealth offer to mobile network operators, healthcare service providers, pharmaceutical companies and other players in the value chain?

What strategies should mobile network operators, wireless infrastructure & device OEMs, healthcare service providers, pharmaceutical companies and application developers adopt to capitalize on the mHealth opportunity?
How big is the mHealth market, and how much revenue will it generate in 2020?
What will be the installed base of mHealth M2M connections in 2020?
How many mHealth centric wearable devices will be shipped in 2020?
What particular submarkets does the mHealth ecosystem constitute?
What geographical regions, countries and submarkets offer the greatest growth potential for mHealth?

Who are the key players in the mHealth market?
What level of cost savings can mHealth facilitate for healthcare service providers in each region?
What are the key applications of LTE in the mHealth market?
What considerations should be taken into account to devise a successful mHealth strategy for a hospital?

Key Findings

The report has the following key findings:

Driven by the thriving ecosystem, SNS Research estimates that the mHealth market will account for over $18 Billion in 2016 alone
Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Research estimates further growth at a CAGR of 40% over the next 5 years
SNS Research estimates that mHealth centric wearable devices will account for over 130 Million unit shipments by the end of 2020. In order to gain valuable insights from the data generated by these devices, healthcare providers and other stakeholders are increasingly investing in Big Data and analytics technology

SNS Research estimates that Big Data and analytics technology investments in the healthcare sector will account for over $4 Billion by 2020, following a CAGR of over 14% between 2015 and 2020
In a bid to reduce error rates and enhance patient monitoring, pharmaceutical companies are increasingly incorporating smartphone and tablet based monitoring apps in their clinical trials
mHealth has the potential to dramatically reduce the costs of healthcare operations, while improving the quality of healthcare. SNS Research estimates that by the end of 2016, mHealth could represent up to $340 Billion in annual healthcare cost savings worldwide

Browse Our More Healthcare Related Reports: http://www.marketresearchreports.biz/category/56

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

To View The Top Related News: http://www.marketresearchreports.biz/articles

Contact 
Mr. Nachiket 
90 Sate Street, Suite 700 
Albany, NY 12207 
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/

Market Study On E-Clinical Solution Software Global Market Research: Asia To Witness Highest Growth By 2020

The "Global Market Study On E-Clinical Solution Software: Asia To Witness Highest Growth By 2020" is a professional and in-depth study on the current state of the Healthcare Industry

E-clinical solution is software that helps researchers easily manage and analyze clinical data. It helps clinical research organizations, pharmaceutical, biotechnology, medical device, and research organizations to magnify their clinical research investment through the use of innovative technologies. Clinical trials are research studies to inspect safety and efficacy of drugs, medical devices, and therapeutic products for humans before they are launched in the market. Growing penetration of computers and the Internet worldwide is driving the application of e-clinical solution software in the clinical trials industry. E-clinical solution software is used widely in the management of clinical trials due to its effectiveness over paper process.

North America dominates the global market for e-clinical solution software due to increasing number of clinical trials in the region. The market in Asia is expected to show high growth rates over the next five years. China and India are expected to be the fastest growing e-clinical solution software markets in Asia. Major key driving forces for the e-clinical solution software market in emerging countries are large pool of patients, increasing healthcare awareness, and increasing clinical trial outsourcing in these regions.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/320645

Increasing number of clinical trials, rising need for improved data standardization and reducing the time consumed during clinical trial process, and increasing spending on clinical research and development in the pharmaceutical industry are key growth drivers for the e-clinical solution software market. In addition, increasing clinical trial outsourcing is expected to provide opportunities for new market entrants, which would further drive growth of the e-clinical solution software market. On the other hand, long approval times for clinical trials, high costs of implementation, and lack of skilled manpower are major concerns for the industry. Pharmaceutical and biopharmaceutical companies require approval from competent regulatory authorities in every country before starting a clinical trial. Another challenge faced by the e-clinical solution software market is the lack of high-speed broadband facilities in remote areas. Rising number of mergers, acquisitions, collaborations, and partnerships are major trends in the global e-clinical solution software market.

This report provides in-depth analysis and estimation of the e-clinical solution software market for the period 2014–2020, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics, including market drivers, restraints, trends, and strategic developments has been provided in the report. The e-clinical solution software market is categorized on the basis of mode of delivery, end user, product, and geography. Based on mode of delivery, the e-clinical solution software market comprises web-based e-clinical solution software, cloud-based e-clinical solution software, and licensed enterprise e-clinical solution software. Based on product type, the market comprises clinical data management system, clinical trial management system, electronic clinical outcome assessment solution, randomization and trial supply, and safety solution.

Browse More Healthcare Related Reports: http://www.marketresearchreports.biz/category/139

In the geographical analysis, the report identifies and analyzes market size and forecast of North America, Europe, Asia and Rest of the World (RoW). North America is further segmented into the U.S and rest of North America. Similarly, Europe is further segmented into Germany, France and Poland. Asia is further segmented into South Korea and China. Major major players in the e-clinical solution software market are Oracle Corporation, Medidata Solutions, PAREXEL International Corporation, BioClinica, OmniComm Systems. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability and financial overview.

Browse Our Press Releases by Prnewswire: http://www.marketresearchreports.biz/category/56

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

To View The Top Related News: http://www.marketresearchreports.biz/articles

Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/